Valuation : Bionik Laboratories Corp.

Market Cap 12 10.31 9.71 8.86 16.56 1.14T 16.62 115.03 44.45 581.77 45.04 44.07 1.84T P/E 2022
-0.21x
P/E 2023 -0.56x
Enterprise Value 19.85L 17.06L 16.07L 14.65L 27.39L 19Cr 27.5L 1.9Cr 73.53L 9.62Cr 74.51L 72.9L 30Cr EV / Sales 2022
0.17x
EV / Sales 2023 2.65x
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
1 day-99.90%
6 months+9,900.00%
Current year+9,900.00%
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.5
5 years 0
Extreme 1.0E-6
2.9
10 years 0
Extreme 0
222.02
Manager TitleAgeSince
Chief Executive Officer 46 14/07/2021
Director TitleAgeSince
Director/Board Member 35 18/03/2019
Director/Board Member 70 01/09/2017
Director/Board Member 46 13/10/2022
Date Insider Type Main position Quantity % Market Cap. Importance
13/06/23 Conversion

Chairman

1,86,112 1.4416%
13/06/23 Conversion

Director

31,02,878 24.0337%
09/06/23 Buy

Director

1,80,555 1.3985%
Change 5-day change 1-year change 3-year change Capi.($)
-99.90%-.--%-.--%-99.96% 1.26T
+0.44%+0.86%+24.21%+16.87% 22TCr
-0.19%-1.01%+3.13%-17.52% 14TCr
+0.88%-4.34%-24.84%+18.45% 12TCr
-0.04%-6.49%-58.42%-16.54% 6.52TCr
-0.62%-5.03%+7.44%+16.35% 5TCr
-0.79%-1.55%-18.62%-13.39% 5.05TCr
-1.43%-3.45%+12.97%+26.98% 4.14TCr
+0.47%-0.25%+30.85%+53.59% 3.96TCr
-2.87%-1.03%+108.80%+29.45% 3.19TCr
Average -10.51%-1.74%+8.55%+1.43% 7.69TCr
Weighted average by Cap. -0.20%-1.80%+4.71%+8.78%

Financials

2022 2023
Net sales 12.74L 10.95L 10.31L 9L 17.58L 12Cr 17.65L 1.22Cr 47.18L 6.18Cr 47.81L 46.78L 20Cr 18.05L 15.51L 14.61L 13.32L 24.91L 17Cr 25.01L 1.73Cr 66.87L 8.75Cr 67.76L 66.3L 28Cr
Net income -1.04Cr -89.44L -84.25L -76.8L -1.44Cr -99Cr -1.44Cr -9.98Cr -3.86Cr -50Cr -3.91Cr -3.82Cr -159.6Cr -49.46L -42.5L -40.04L -36.5L -68.26L -47Cr -68.52L -4.74Cr -1.83Cr -24Cr -1.86Cr -1.82Cr -76Cr
Net Debt -19.91L -17.11L -16.12L -14.69L -27.48L -19Cr -27.59L -1.91Cr -73.76L -9.65Cr -74.75L -73.14L -31Cr 19.85L 17.06L 16.07L 14.65L 27.39L 19Cr 27.5L 1.9Cr 73.53L 9.62Cr 74.51L 72.9L 30Cr
Logo Bionik Laboratories Corp.
Bionik Laboratories Corp. is a healthcare company focused on supplying solutions to those with movement impairments. Its product portfolio includes three InMotion Robots for rehabilitation following stroke and other neurological conditions and four products in varying stages of development. The InMotion robots offer patient-adaptive therapy, intended to restore upper-extremity motor control for a range of neurological conditions and recovery stages, including early recovery from acute stroke. InMotion Robots also provide objective evaluation assessments intended to measure and report the patient’s level of motor impairment and progress during therapy. Its solutions include InMotion Therapy, InMotion ARM, InMotion ARM/HAND, InMotion EVAL, InMotion Connect, InMotion for Physical Therapy, and InMotion for Occupational Therapy. InMotion Robotics provides the occupational therapist with a range of useful protocols designed to reduce many types of upper extremity neurological impairments.
Employees
-
  1. Stock Market
  2. Stocks
  3. BNKL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!